5/24/2024  5:35:22 PM Chg. +0.420 Volume Bid5:35:22 PM Ask5/24/2024 Market Capitalization Dividend Y. P/E Ratio
46.200EUR +0.92% 55,340
Turnover: 2.55 mill.
-Bid Size: - -Ask Size: - 944.4 mill.EUR 1.10% 36.02

Business description

The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The three business segments are: Radiation Therapy, Isotope Products and Radiopharma. Eckert & Ziegler was founded in 1997 as a holding company.
 

Management board & Supervisory board

CEO
Dr. Harald Hasselmann
Management board
Jutta Ludwig, Frank Yeager
Supervisory board
Dr. Andreas Eckert, Albert Rupprecht, Dr. Edgar Löffler, Frank Perschmann, Prof. Dr. Helmut Grothe, Paola Eckert-Palvarini
 

Company data

Name: Eckert & Ziegler Strahlen- und Medizintechnik AG
Address: Robert-Rössle-Str. 10,D-13125 Berlin
Phone: +49-30-941084-0
Fax: +49-30-941084-112
E-mail: info@ezag.de
Internet: www.ezag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 59.16%
IPO date: -

Investor relations

Name: Karolin Riehle
IR phone: +49-30-941084-138
IR Fax: -
IR e-mail: karolin.riehle@ezag.de

Company calendar

CW 22 | 5/29/2024 Ex-Dividend
CW 22 | 5/31/2024 Dividend Payment
CW 26 | 6/26/2024 General Shareholder Meeting
CW 32 | 8/9/2024 Interim Report 2nd Quarter/6 Months
CW 46 | 11/14/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

free float
 
60.82%
Eckert Wagniskapital und Frühphasenfinanzierung GmbH
 
31.13%
Norges bank
 
3.36%
Ameriprise Financial
 
2.98%
Eckert & Ziegler AG
 
1.70%
Others
 
0.01%